Lupin spins out two oncology programs to Kaveri Therapeutics to advance its oncology strategy EP News Bureau Jul 21, 2026 Global pharma major Lupin, announced the strategic spin-out of two oncology programs – LNP7457 (PRMT5) and LNP8701 (SOS1), …
